Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:2.7.11.2 (
PDK1
)
2,238
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Differential anti-prion activity of polylysine enantiomers was studied. Based on our recent discovery that poly-L-lysine (PLK) is a potent anti-prion agent, we investigated suppression of prions in cultured cells using poly-D-lysine (
PDK
). The results showed that
PDK
was more efficacious than PLK to inhibit prions. Protein misfolding cyclic amplification assay demonstrated improved efficacy of
PDK
in inhibiting
plasminogen
-mediated prion propagation, corresponding to the enantio-preference of
PDK
observed in cultured cells. Furthermore, our study demonstrated that polylysines formed a complex with
plasminogen
. These results propose to hypothesize a plausible mechanism that elicits prion inhibition by polylysine enantiomers.
...
PMID:Preference toward a polylysine enantiomer in inhibiting prions. 2317 88
Glioblastoma (GB) is the most common and deadly type of primary malignant brain tumor with an average patient survival of only 15-17 months. GBs typically have hypoxic regions associated with aggressiveness and chemoresistance. Using patient derived GB cells, we characterized how GB responds to hypoxia. We noted a hypoxia-dependent glycolytic switch characterized by the up-regulation of HK2, PFKFB3, PFKFB4, LDHA,
PDK1
,
SLC2A1
/GLUT-1,
CA9
/CAIX, and
SLC16A3
/MCT-4. Moreover, many proangiogenic genes and proteins, including VEGFA, VEGFC, VEGFD,
PGF
/PlGF, ADM, ANGPTL4, and
SERPINE1/
PAI-1 were up-regulated during hypoxia. We detected the hypoxic induction of invasion proteins, including the
plasminogen
receptor, S100A10, and the urokinase plasminogen activator receptor, uPAR. Furthermore, we observed a hypoxia-dependent up-regulation of the autophagy genes,
BNIP-3
and
DDIT4
and of the multi-functional protein, NDRG1 associated with GB chemoresistance; and down-regulation of
EGR1
and
TFRC
(Graphical abstract). Analysis of GB patient cohorts' revealed differential expression of these genes in patient samples (except
SLC16A3
) compared to non-neoplastic brain tissue. High expression of
SLC2A1
,
LDHA
,
PDK1
,
PFKFB4
,
HK2
,
VEGFA
,
SERPINE1
,
TFRC
, and
ADM
was associated with significantly lower overall survival. Together these data provide important information regarding GB response to hypoxia which could support the development of more effective treatments for GB patients.
...
PMID:Investigating Glioblastoma Response to Hypoxia. 3286 90